Requip is manufactured by GlaxoSmithKline.
This medication is licensed to treat two conditions:
- Parkinson's disease -- Requip has been approved to treat signs and symptoms of Parkinson's disease.
- Restless legs syndrome (RLS) -- The medication also has been approved to treat moderate to severe primary restless legs syndrome.
Requip has not been approved for use in children.
Requip is part of a class of drugs called dopamine agonists. Dopamine resides in the part of the brain that coordinates muscle movement. When there is less dopamine in this area, muscles tend to become stiff and rigid. Requip helps increase the amount of dopamine in your brain, "fooling" your nervous system into thinking that it has more dopamine than it really does. This helps reduce the symptoms of both Parkinson's disease and restless legs syndrome.
HealthSavvy Sign In
|
